MedElevator
Войти в исследования General thoracic and cardiovascular surgery · 2026
Risk factors associated with saphenous vein graft in-stent restenosis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Amirzadegan Alireza, Ebadi Reza, Khederlou Hamid, Karami Dehkordi Pouya, Karimi Zahra
Аннотация
OBJECTIVE: This study examined the risk factors of in-stent restenosis (ISR) group after saphenous vein grafts (SVGs) percutaneous coronary intervention.
METHODS: From March 2007 to February 2021, we collected 385 cases of SVGs percutaneous coronary intervention at the Tehran heart center. Patients experiencing ischemic symptoms were examined during follow-ups by cardiologists, who recommended a second coronary artery angiography. On the basis of coronary artery angiography, the cases were classified as ISR group (n = 284) or non-ISR group (n = 101). The medical history, biochemical indicators, coronary artery lesion features, and stent characteristics were retrospectively evaluated. Using univariate and multivariable Cox regression, risk factors for ISR group have been discovered.
RESULTS: SVG ISR group was verified in 284 of the total number of patients (73.8%). The median length of follow-up was 8.6 years (95% CI = 7.1-10.0 years). Lower body mass index (HR = 0.95, 95% CI = 0.92-0.98, p = 0.006), lower left ventricular ejection fraction (HR = 0.94, 95% CI = 0.91-0.99, p = 0.001), and longer stent length (HR = 1.03, 95% CI = 1.01-1.05, p = 0.002), remained independently associated with ISR group after multivariable analysis.
CONCLUSION: Lower body mass index, lower left ventricular ejection fraction, and longer stent length are independent predictors of ISR group after SVGs percutaneous coronary intervention.
METHODS: From March 2007 to February 2021, we collected 385 cases of SVGs percutaneous coronary intervention at the Tehran heart center. Patients experiencing ischemic symptoms were examined during follow-ups by cardiologists, who recommended a second coronary artery angiography. On the basis of coronary artery angiography, the cases were classified as ISR group (n = 284) or non-ISR group (n = 101). The medical history, biochemical indicators, coronary artery lesion features, and stent characteristics were retrospectively evaluated. Using univariate and multivariable Cox regression, risk factors for ISR group have been discovered.
RESULTS: SVG ISR group was verified in 284 of the total number of patients (73.8%). The median length of follow-up was 8.6 years (95% CI = 7.1-10.0 years). Lower body mass index (HR = 0.95, 95% CI = 0.92-0.98, p = 0.006), lower left ventricular ejection fraction (HR = 0.94, 95% CI = 0.91-0.99, p = 0.001), and longer stent length (HR = 1.03, 95% CI = 1.01-1.05, p = 0.002), remained independently associated with ISR group after multivariable analysis.
CONCLUSION: Lower body mass index, lower left ventricular ejection fraction, and longer stent length are independent predictors of ISR group after SVGs percutaneous coronary intervention.